These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1478273)

  • 1. Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia.
    Larsson R; Jonsson B; Csoka K; Kristensen J; Nilsson K; Nygren P
    Eur J Pharmacol; 1992 Dec; 228(4):237-40. PubMed ID: 1478273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.
    Martinsson P; Nygren P; Fridborg H; Nilsson K; Kristensen J; Larsson R
    Eur J Clin Pharmacol; 1997; 52(3):199-203. PubMed ID: 9218926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
    Grey MR; Burgess R; Fisher A; Yin JA
    Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A-induced cell kill in vitro in various clinical-hematological types of B-cell chronic lymphocytic leukemia.
    Koski T; Aine R; Vilpo L; Vilpo J
    Leuk Res; 2000 Oct; 24(10):805-12. PubMed ID: 10996198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia.
    Nishii K; Katayama N; Mitani H; Matsumoto T; Miwa H; Kita K; Shiku H
    Int J Hematol; 2000 Jan; 71(1):59-65. PubMed ID: 10729995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia.
    Cabrelle A; Maschio N; Carraro S; Frezzato F; Binotto G; Gattazzo C; Miorin M; Agostini C; Zambello R; Pandolfi F; Semenzato G; Trentin L
    J Biol Regul Homeost Agents; 2009; 23(4):239-50. PubMed ID: 20003763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia.
    Eisterer W; Neyer U; Hilbe W; Diem G; Ohlschlegel C; Ludescher C; Thaler J
    Nephron; 1996; 72(3):468-71. PubMed ID: 8852499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A in the treatment of refractory B chronic lymphocytic leukemia (B-CLL).
    Van Den Neste E; Maerevoet M; Martiat P; Ferrant A; Delannoy A; Michaux JL
    Leukemia; 1995 Jun; 9(6):1102-3. PubMed ID: 7596177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine A in chronic lymphocytic leukemia: dual anti-leukemic and immunosuppressive role?
    Wright SJ; Keating MJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):131-6. PubMed ID: 8750634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A in the treatment of B-chronic lymphocytic leukemia (B-CLL).
    Bergui L; Gregoretti MG; Caligaris-Cappio F
    Leukemia; 1994 Jul; 8(7):1245-6. PubMed ID: 8035620
    [No Abstract]   [Full Text] [Related]  

  • 11. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cytotoxic compounds in poor-prognostic chronic lymphocytic leukemia.
    Norberg M; Lindhagen E; Kanduri M; Rickardson L; Sundström C; Stamatopoulos K; Rosenquist R; Åleskog A
    Anticancer Res; 2012 Aug; 32(8):3125-36. PubMed ID: 22843883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A inhibits cytokine-induced proliferation in B-chronic lymphocytic leukemia.
    Schmid M; Merk B; Porzsolt F
    Leuk Lymphoma; 1994 Oct; 15(3-4):317-25. PubMed ID: 7866281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.
    Rosati E; Sabatini R; Tabilio A; Di Ianni M; Bartoli A; Marconi P
    Leuk Res; 2005 Jul; 29(7):829-39. PubMed ID: 15927678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells.
    Cagnetta A; Caffa I; Acharya C; Soncini D; Acharya P; Adamia S; Pierri I; Bergamaschi M; Garuti A; Fraternali G; Mastracci L; Provenzani A; Zucal C; Damonte G; Salis A; Montecucco F; Patrone F; Ballestrero A; Bruzzone S; Gobbi M; Nencioni A; Cea M
    Clin Cancer Res; 2015 Sep; 21(17):3934-45. PubMed ID: 25964294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
    Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
    Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational anticancer drugs.
    Fridborg H; Nygren P; Larsson R
    Anticancer Drugs; 1995 Feb; 6(1):64-9. PubMed ID: 7756685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression.
    Moga E; Cantó E; Vidal S; Juarez C; Sierra J; Briones J
    Exp Hematol; 2011 Nov; 39(11):1064-71. PubMed ID: 21864486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.